Safety and Efficacy of Isomyosamine in Reducing Inflammation and Treating Muscle Loss in Older Adults After Hip or Thigh Bone Fractures

Clinical trial NCT06942182 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06942182
Sponsor: TNF Pharmaceuticals, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sarcopenia in Elderly Frailty Frailty/Sarcopenia Frailty in Older Adults

Start date: 2025-05-01
Primary completion: 2026-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.